Edison T. Liu
Vice President for Healthcare Outcomes Policy and
Oncology and Molecular Radiation Sciences
University of Washington School of Medicine, Seattle, WA.
Norway
Biography
Edison Liu was born in Hong Kong, China, and emigrated to the United States in 1957. He received his bachelor's degree (Phi Beta Kappa) in chemistry and psychology from Stanford University where he remained to complete his M.D. in 1978. This was followed by internship and residency in internal medicine at Washington University, St. Louis, and clinical cancer fellowships at Stanford University (Oncology), and at the University of California at San Francisco (Hematology). He then pursued post-doctoral studies as a Damon-Runyan Cancer Research Fellow at the University of California at San Francisco in the laboratory of Dr. J. Michael Bishop identifying transforming genes in human leukemic states. In 1987 when he joined the faculty of Medicine at the University of North Carolina at Chapel Hill. T Edison Liu was born in Hong Kong, China, and emigrated to the United States in 1957. He received his bachelor's degree (Phi Beta Kappa) in chemistry and psychology from Stanford University where he remained to complete his M.D. in 1978. This was followed by internship and residency in internal medicine at Washington University, St. Louis, and clinical cancer fellowships at Stanford University (Oncology), and at the University of California at San Francisco (Hematology). He then pursued post-doctoral studies as a Damon-Runyan Cancer Research Fellow at the University of California at San Francisco in the laboratory of Dr. J. Michael Bishop identifying transforming genes in human leukemic states. In 1987 when he joined the faculty of Medicine at the University of North Carolina at Chapel Hill. T
Research Interest
Dr. Liu has received a number of awards including the Leukemia Society Scholar (1991-1996), the Brinker International Award for basic science research in Breast Cancer (1996), the Rosenthal Award from the American Association for Cancer Research for his work in elucidating the importance of the HER-2 gene as a predictive marker for breast cancer adjuvant therapy (2000). Dr. Liu was recently the recipient of the President’s Public Service Medal for his work in helping Singapore resolve the SARS crisis.